Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Assura Plc LSE:AGR London Ordinary Share GB00BVGBWW93 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -0.18% 54.25 54.20 54.30 54.60 52.70 53.35 10,160,076 16:35:15
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Food & Drug Retailers 136.9 155.8 5.6 9.7 1,604

Assura PLC Result of AGM

06/07/2022 3:32pm

UK Regulatory (RNS & others)


Assura (LSE:AGR)
Historical Stock Chart


From Jun 2022 to Dec 2022

Click Here for more Assura Charts.

TIDMAGR

RNS Number : 5737R

Assura PLC

06 July 2022

6 July 2022

Assura plc ("Company")

Result of AGM

Assura plc announces that at its Annual General Meeting held earlier today, each of the resolutions submitted to the meeting (as set out in the Notice of the Meeting dated 1 June 2022) were passed by the requisite majorities on a poll.

 
                                                                            Total Votes 
                                                                             Cast (% 
                                          %                                  of issued        Votes 
 Resolution               For              For    Against       % Against    share capital)    Withheld 
 1. To receive 
  the Company's                                                               2,555,443,690 
  report and accounts     2,536,398,504   99.25    19,045,186        0.75           (86.43)   4,911,379 
 2. To approve 
  the Directors' 
  Remuneration                                                                2,560,293,403 
  Policy                  2,512,011,438   98.11    48,281,965        1.89           (86.60)      61,666 
 3. To approve 
  the Directors' 
  Remuneration                                                                2,560,278,185 
  Report                  2,522,696,378   98.53    37,581,807        1.47           (86.60)      76,884 
 4. To re-appoint 
  Ernst & Young 
  LLP as auditor                                                              2,560,340,293 
  of the Company          2,511,745,712   98.10    48,594,581        1.90           (86.60)      14,776 
 5. To authorise 
  the Audit Committee 
  to determine 
  the auditor's                                                               2,560,299,796 
  remuneration            2,526,741,114   98.69    33,558,682        1.31           (86.60)      55,273 
 6. To re-elect 
  Ed Smith as 
  a Director of                                                               2,560,322,868 
  the Company             2,474,673,155   96.65    85,649,713        3.35           (86.60)      32,201 
 7. To re-elect 
  Louise Fowler 
  as a Director                                                               2,560,325,989 
  of the Company          2,544,566,232   99.38    15,759,757        0.62           (86.60)      29,080 
 8. To re-elect 
  Jonathan Murphy 
  as a Director                                                               2,560,325,989 
  of the Company          2,540,837,168   99.24    19,488,821        0.76           (86.60)      29,080 
 9. To re-elect 
  Jayne Cottam 
  as a Director                                                               2,560,325,075 
  of the Company          2,532,695,523   98.92    27,629,552        1.08           (86.60)      29,994 
 10. To re-elect 
  Jonathan Davies 
  as a Director                                                               2,560,325,989 
  of the Company          2,545,589,609   99.42    14,736,380        0.58           (86.60)      29,080 
 11. To re-elect 
  Sam Barrell 
  as a Director                                                               2,560,325,075 
  of the Company          2,545,932,676   99.44    14,392,399        0.56           (86.60)      29,994 
 12. To re-elect 
  Emma Cariaga 
  as a Director                                                               2,560,325,075 
  of the Company          2,559,436,807   99.97       888,268        0.03           (86.60)      29,994 
 13. To re-elect 
  Noel Gordon 
  as a Director                                                               2,560,325,075 
  of the Company          2,559,293,587   99.96     1,031,488        0.04           (86.60)      29,994 
 14. To authorise 
  the Directors                                                               2,559,342,877 
  to allot shares         2,445,882,244   95.57   113,460,633        4.43           (86.56)   1,012,192 
 15. To empower 
  the Directors 
  to disapply 
  pre-emption                                                                 2,555,125,245 
  rights                  2,554,885,524   99.99       239,721        0.01           (86.42)   5,229,824 
 16. To empower 
  the Directors 
  to disapply 
  pre-emption 
  rights in connection 
  with an acquisition 
  or specified                                                                2,555,130,287 
  capital investment      2,526,205,951   98.87    28,924,336        1.13           (86.42)   5,224,782 
 17. To authorise 
  the market purchase 
  of the Company's                                                            2,557,084,292 
  own shares              2,556,408,332   99.97       675,960        0.03           (86.49)   3,270,777 
 18. To authorise 
  the Company 
  to call any 
  general meeting, 
  other than the 
  Annual General 
  Meeting, by 
  not less than 
  14 clear days'                                                              2,560,342,517 
  notice                  2,402,436,333   93.83   157,906,184        6.17           (86.60)      12,552 
 

Resolutions 1-14 were passed as ordinary resolutions. Resolutions 15-18 were passed as special resolutions. Votes 'For' include votes at the discretion of the Chairman.

Notes:

1. The percentages above are rounded to two decimal places.

2. A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "for" and "against" a resolution.

3. The number of ordinary shares in issue on the share register at 6.00pm on 5 July 2022 was 2,956,564,843 of which the Total Voting Rights figure was 2,956,564,843.

Copies of resolutions 15-18, being resolutions other than resolutions concerning ordinary business passed by the Company at the above AGM, have been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

- Ends -

For more information, please contact:

 
 
    Assura plc                            Tel: 01925 945354 
  Orla Ball, Company Secretary          Email: Investor@assura.co.uk 
   David Purcell, Investor Relations 
   Director 
  FGS Global                            Tel: 0207 251 3801 
   Gordon Simpson                        Email: Assura@fgsglobal.com 
   James Thompson 
 

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Warrington, UK - caring for more than 600 primary healthcare buildings, from which almost seven million patients are served.

A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2022, Assura's portfolio was valued at GBP2,752 million.

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026.

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

Further information is available at www.assuraplc.com

* EPRA is a registered trademark of the European Public Real Estate Association

Assura plc LEI code: 21380026T19N2Y52XF72

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGSSFFLMEESEDW

(END) Dow Jones Newswires

July 06, 2022 10:32 ET (14:32 GMT)

1 Year Assura Chart

1 Year Assura Chart

1 Month Assura Chart

1 Month Assura Chart
Your Recent History
LSE
AGR
Assura
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20221209 23:57:42